Press release
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.A more than 150-page report to understand trends, opportunity and forecast in MRD testing market to 2031 by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.
Within this market, hospitals and specialty clinics will remain the largest segment.
Download sample by clicking on MRD testing market
APAC is expected to witness highest growth over the forecast period.
Labcorp, F. Hoffmann-La Roche, Guardant Health, Sysmex Corporation, Neogenomics Laboratories, Adaptive Biotechnologies Corporation, Archerdx, Asuragen, Arup Laboratories are the major suppliers in the MRD testing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Hi-Fi System Market
Bearing for Mechanical and Electrical Product
Telecom Electronic Manufacturing Service Market
Timing Device Market
Visual Inspection Microscope Market
Construction Waste Crusher Market
Nonwovens for Construction Market
OSB Panel for Construction Market
8951 Cypress Waters Blvd, Suite 160 Dallas, TX 75019, USA
Tel: +1-972-636-5056
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031 here
News-ID: 4041636 • Views: …
More Releases from Lucintel

Lucintel Forecasts the Global Truck Substation Market is expected to grow with a …
According to a market report by Lucintel, the future of the global truck substation market looks promising with opportunities in the energy, infrastructure, and industrial markets. The global truck substation market is expected to grow with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are growing demand for reliable electricity transmission in remote areas and on-going advancement in power electronics, communication systems, and control…

Lucintel Forecasts the Global Underhood Work Light Market is expected to grow wi …
According to a market report by Lucintel, the future of the global underhood work light market looks promising with opportunities in the super and hypermarket, convenience store, specialist retailer, online retailer, and directly sale markets. The global underhood work light market is expected to grow with a CAGR of 3.8% from 2024 to 2030. The major drivers for this market are growing demand for efficient automotive maintenance tools owing to…

Lucintel Forecasts the Global Steering Unit for Agriculture Machinery Market is …
According to a market report by Lucintel, the future of the global steering unit for agriculture machinery market looks promising with opportunities in the small tractor, backhoe loader, and combine and harvester markets. The global steering unit for agriculture machinery market is expected to grow with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are increasing mechanization and modernization of agricultural practices and on-going…
Lucintel Forecasts the Global Urban Microgrid System Market is expected to grow …
According to a market report by Lucintel, the future of the global urban microgrid system market looks promising with opportunities in the public utility, shopping mall, and hotel markets. The global urban microgrid system market is expected to grow with a CAGR of 21.0% from 2024 to 2030. The major drivers for this market are rising demand for resilient, sustainable, and decentralized energy solutions and growing need to modernize the…
More Releases for MRD
Minimal Residual Disease (MRD) Testing Market Booming with Hemato-Oncology Focus …
Minimal Residual Disease (MRD) Testing Market Snapshot
The Minimal Residual Disease (MRD) Testing Market is projected to grow from USD 2.58 billion in 2025 to USD 5.64 billion by 2032, at a CAGR of 11.8% during the forecast period.
Coherent Market Insights proudly presents its latest Minimal Residual Disease (MRD) Testing Market Research Report, delivering a detailed examination of the U.S. Minimal Residual Disease (MRD) Testing Market outlook from 2025 to 2032.…
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031.
According to a market report by Lucintel, the future…
Global MRD Testing Market Set to Reach USD 3.72 Billion by 2030
➤ Global Minimal Residual Disease (MRD) Testing Market to Reach USD 3.72 Billion by 2030, Driven by Technological Advancements and Rising Cancer Incidence
The global Minimal Residual Disease (MRD) Testing Market is projected to expand from USD 1.60 billion in 2023 to USD 3.72 billion by 2030, registering a robust Compound Annual Growth Rate (CAGR) of 12.8% during the forecast period.
➤ Competitive Landscape and Regional Demand
The MRD testing market…
MRD Testing Market Projected To Witness Substantial Growth, 2024-2031
The Latest research report on the MRD Testing Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the MRD Testing Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies,…
Liqomics Launches LymphoVista: Breakthrough in Minimal Residual Disease (MRD) Mo …
Image: https://www.getnews.info/uploads/47d7fad53008388024cd78873530f9ca.png
Liqomics is proud to announce the launch of LymphoVista
LymphoVista (https://liqomics.com/detect-lymphoma-lymphovista/) is an advanced ctDNA-based assay specifically designed for minimal residual disease (MRD) monitoring and genotyping in lymphoma patients. LymphoVista leverages high-sensitivity circulating tumor DNA (ctDNA) detection, setting a new standard in MRD testing across lymphomas including Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Central Nervous System (CNS) Lymphomas and Follicular Lymphoma.
Revolutionizing MRD Testing in Hodgkin Lymphoma and Other Lymphomas
LymphoVista…
MRD Testing Market Expected to Grow at 14.7% CAGR by 2030
The latest report published by VynZ Research, Global MRD Testing Market - Analysis and Forecast (2025-2030), offers a comprehensive analysis of the industry, which comprises insights on the market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.
Global MRD Testing Market will at USD 3.4 Billion in 2030, and it is anticipated to grow at CAGR 14.7% during the forecast period (2025-2030)…